Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can you recognize autoimmune hepatitis?

E L Krawitt1

  • 1University of Vermont College of Medicine, Burlington, USA. ekrawitt@zoo.uvm.edu

Postgraduate Medicine
|August 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular and Molecular Mechanisms of Autoimmune Hepatitis.

Annual review of pathology·2017
Same author

Hepatitis C virus infection: a risk factor for Parkinson's disease.

Journal of viral hepatitis·2016
Same author

Glutathione-S-Transferase M1 null genotype in autoimmune hepatitis.

Digestive diseases and sciences·2001
Same author

Anti-Saccharomyces cerevisiae antibodies in autoimmune liver disease.

The American journal of gastroenterology·2001
Same author

Minocycline-induced hepatitis.

The American journal of gastroenterology·2000
Same author

Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration. Consensus Interferon Study Group.

The American journal of gastroenterology·1999
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
Same journal

Risk of adverse effects of the concomitant use of statins with calcium channel blockers: a systematic review and meta-analysis.

Postgraduate medicine·2026
Same journal

Association between frailty and major chronic disease-free life expectancy: a large community-based longitudinal study.

Postgraduate medicine·2026
See all related articles

Autoimmune hepatitis can mimic other liver diseases, making early diagnosis crucial. Prompt corticosteroid treatment can significantly improve patient outcomes and prevent severe liver damage.

Area of Science:

  • Hepatology
  • Immunology
  • Internal Medicine

Background:

  • Autoimmune hepatitis (AIH) presents diagnostic challenges due to its non-specific initial presentation.
  • AIH can be mistaken for other liver conditions, potentially delaying appropriate treatment.
  • Early intervention in AIH is critical for preventing long-term liver damage.

Purpose of the Study:

  • To outline key diagnostic indicators for autoimmune hepatitis.
  • To discuss effective management strategies for autoimmune hepatitis.
  • To emphasize the importance of early recognition for improved patient prognosis.

Main Methods:

  • Review of diagnostic criteria for autoimmune hepatitis.
  • Analysis of clinical presentation and laboratory findings suggestive of AIH.

Related Experiment Videos

  • Discussion of treatment protocols, focusing on corticosteroid therapy.

    • Main Results:

    • No single diagnostic test exists for autoimmune hepatitis.
    • Early diagnosis and corticosteroid therapy lead to favorable patient responses.
    • Timely management can mitigate serious liver damage.

    Conclusions:

    • Effective management of autoimmune hepatitis relies on recognizing subtle diagnostic clues.
    • Corticosteroid therapy is highly effective in treating autoimmune hepatitis.
    • Improving patient quality of life is achievable through prompt diagnosis and treatment.